Results 121 to 130 of about 16,114 (140)

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma. [PDF]

open access: yesN Engl J Med, 2018
Motzer RJ   +32 more
europepmc   +1 more source

Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up. [PDF]

open access: yesJpn J Clin Oncol, 2020
Tomita Y   +11 more
europepmc   +1 more source

ARIA 2019, Allerjik Rinite Tedavi Yaklaşımı-Türkiye. [PDF]

open access: yesTurk Thorac J, 2020
Yorgancıoğlu AA   +12 more
europepmc   +1 more source

Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial. [PDF]

open access: yesLancet Oncol, 2019
Motzer RJ   +38 more
europepmc   +1 more source

Spatiotemporal dynamics of cholera epidemics in Ethiopia: 2015-2021. [PDF]

open access: yesSci Rep
Moore S   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy